Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus Vaccine
Clinical trial NCT01255410 · COMPLETED
Trial details
- NCT number
- NCT01255410
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2014-10-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.